Caprelsa - direct healthcare professional communication (DHPC)

vandetanib
DHPCHuman

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

Over

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documenten

Direct healthcare professional communication (DHPC): Caprelsa (vandetanib): Restriction of indication

English (EN) (154.03 kB - PDF)

Publicatiedatum:
Bekijk

Key facts

Medicine name
Caprelsa
Active substance
vandetanib
Therapeutic area (MeSH)
Thyroid Neoplasms
Procedure number
EMEA/H/C/002315/II/0043
Regulatory outcome
Variation
DHPC type
Restriction of indication
Human ATC codes
L01XE

Share this page